Archives

by in
Entry Author Date Location
MassChallenge Winner From MIT Aims to Kill Cancer With a “Squeeze” 11/24/14 Boston
East Coast Biotech Roundup: Agios, Vertex, Epizyme, Celldex, & More 11/21/14 Boston
Juno, Less Than a Year Old, Lines up IPO to Fund Cancer Work 11/17/14 Seattle
Deltanoid and Beyond: Madison Legend DeLuca Has More “D” To Play 11/17/14 Wisconsin
Celldex Touts Brain Cancer Vaccine Data, Talks FDA Strategy 11/14/14 New York
Aiming to Boost Innovation, Trinity Fine-Tunes Its Tech Transfer 10/30/14 National
Opsona, And Pharma Backers, Await Day of Reckoning for Kidney Drug 10/29/14 National
East Coast Biotech Roundup: PureTech, Celgene, Unum, Biogen & More 10/24/14 Boston
New Atlas Startup Gets “Quartet” of Backers, $17M For Pain Drugs 10/23/14 Boston
Smart-Bug Maker Synlogic Nabs $5M From Gates Foundation 10/07/14 Boston
What Seattle Needs (Part 2): Dealing With Amgen’s Upcoming Departure 10/07/14 Seattle
Ex-Elan Trio Grabs Their Former Employer’s Kinase Inhibitor Program 09/29/14 San Francisco
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief 09/07/14 Boston
Which Countries Excel in Creating New Drugs? It’s Complicated 09/02/14 Seattle
East Coast Biotech Roundup: Biogen, Civitas, Rhythm, Alkermes, & More 08/29/14 Boston
East Coast Biotech Roundup: NJ Blues, Genzyme, Amicus, Biogen & More 08/25/14 Boston
NJ’s Medicine Chest Thins Again as GE Health Unit Heads for MA 08/19/14 Boston
West Coast Biotech Roundup: Onyx, Calico, Otonomy, Dendreon & More 08/14/14 San Francisco
To Take On New York, Accelerator Makes Big Changes 08/14/14 New York
With $310M and Public Investors Aboard, Is a Juno IPO Next? 08/05/14 Seattle
East Coast Biotech Roundup: Emulate, Accelerator, Retrophin, & More 08/01/14 Boston
Accelerator Bags $51M, Makes Long-Awaited Move to NYC 07/29/14 New York
G1, Out to Shield Body From Chemo, Heads to First Clinical Test 07/28/14 Raleigh Durham
J&J Immunology Exec on Investing at the Crossroads of the Microbiome 07/24/14 National
Seres Makes Push for First Drug, and IPO, of Microbiome Era 07/16/14 Boston
East Coast Biotech Roundup: Bluebird, Moderna, Navitor, & More 06/20/14 Boston
Boston VC Firms, Pharmas Team up on $23.5M Series A For Navitor 06/19/14 Boston
As Its Investors Reap Returns, venBio Aims for a Bigger Second Fund 06/10/14 San Francisco
East Coast Biotech Roundup: Accelerate LI, ASCO, Akebia, & More 06/09/14 Boston
Post-IPO Biotechs Have News, But Big Pharma Drives the ASCO Boat 06/06/14 Boston
Page 2 of 20 « previous page · next page »